Clearmind Medicine to consolidate shares 1-for-8 Oct. 5 on Nasdaq

• Clearmind Medicine will execute a 1-for-8 reverse share split of its common shares.
• Post-split trading on the Nasdaq Capital Market is set to begin Monday, Oct. 5, 2026.
• Issued and outstanding shares are expected to fall to 507,404 from 4,059,227, subject to fractional-share rounding.
• Fractional shares will be rounded up to the nearest whole share.
• Options and warrants will be adjusted proportionately for share count and exercise price; new CUSIP will be 185053709.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-105269), on September 30, 2026, and is solely responsible for the information contained therein.